News 12 Oct. 2012

Curtis Advises Bionomics in Acquisition of Eclipse Therapeutics

New York, October 11, 2012 — Curtis, Mallet-Prevost, Colt & Mosle LLP represented Bionomics Limited in the Australian biotechnology company's acquisition of San Diego-based Eclipse Therapeutics Inc.

The transaction was structured as a stock-for-stock reverse. Additional cash consideration may be payable post-closing upon the achievement of certain milestones.

Bionomics, as a result of the deal, will gain an important strategic base in the United States, the world's largest pharmaceutical market, with the acquisition. The addition of Eclipse will expand Bionomics' oncology pipeline and establish the company as a global leader at the forefront of cancer stem cell therapeutics.

Bionomics, based in Adelaide, is a leading international biotechnology company which discovers and develops innovative therapeutics for cancer and diseases of the central nervous system. Bionomics has small molecule product development programs in the areas of cancer, anxiety, Alzheimer's disease, epilepsy and multiple sclerosis.

Eclipse Therapeutics is a private biotech company that was spun off from Biogen Idec Inc. Eclipse develops drug compounds that target cancer stem cells, the root cause of many cancers.

The Curtis team of attorneys was led by partner Lawrence Goodman and associates Douglas Glazer and Joshua Holt from the Corporate M&A group, partner Alan Berlin and counsel Kuang-Chu Chiang from the Tax group, and counsel Eric Stenshoel from the Intellectual Property practice.

The Curtis Mergers & Acquisition practice group focuses primarily on middle market M&A and private equity transactions across a broad range of industries. Curtis advises both private and public entities and financial sponsors in a broad range of transactional matters, counseling buyers, sellers and targets in connection with mergers, acquisitions, joint ventures, leveraged buy-outs, strategic alliances and other related transactions. The Curtis M&A group has extensive experience in complex cross-border transactions and foreign investments in the United States, Europe, Latin America, the Middle East and Asia.

Curtis, Mallet-Prevost, Colt & Mosle LLP is a leading international law firm providing a broad range of services to clients around the world. Curtis has 16 offices in the United States, Latin America, Europe, Central Asia, and the Middle East. The firm's international orientation has been a hallmark of its practice for nearly two centuries. For more information about Curtis, please visit or follow Curtis on Twitter ( and